|Contingency Management for Drug Problems|
|Monday, November 19, 2018|
|3:30 PM–6:00 PM |
|Independence Hall A|
|Domain: Service Delivery|
|Instruction Level: Basic|
|CE Instructor: Mark Galizio, Ph.D.|
|Chair: Mark Galizio (University of North Carolina Wilmington)|
|Discussant: Maxine Stitzer (Behavioral Pharmacology Research Unit)|
An Overview of Contingency Management Interventions in Substance Abuse Treatment: With Whom is it Effective and Where is it Applied?
|CARLA J. RASH (UConn Health)|
|Carla Rash earned a Ph.D. in clinical psychology from Louisiana State University in 2007. She is currently an assistant professor in the Department of Medicine at UConn Health. Her research interests focus on extending and evaluating addictions treatments, including contingency management interventions, in underserved and health disparity populations. Her work is funded by the National Institute on Drug Abuse, the National Institute on Alcohol Abuse and Alcoholism, and by a career development award from the Connecticut Institute for Clinical and Translational Science.|
Contingency management (CM) interventions are efficacious options for substance abuse treatments, but they are rarely implemented in clinical, non-research settings. In this presentation, we briefly review the evidence support for CM and introduce prize-based CM. We will highlight work that supports CM’s generalizability across diverse patient characteristics and settings. We will conclude with a discussion of potential implementation barriers and examples of real-world implementation efforts.
Contingency Management in the 21st Century: Technology and the Future
|JESSE DALLERY (University of Florida)|
|Jesse is a Professor in the Department of Psychology at the University of Florida, a Licensed Psychologist in the state of Florida, and Deputy Director of the Treatment Development and Implementation Core at the Center for Technology and Behavioral Health at Dartmouth. Jesse received his Ph.D. in Clinical Psychology at Emory University, and completed a postdoctoral fellowship at the Johns Hopkins University School of Medicine in Behavioral Pharmacology. Jesse’s research focuses on integrating information technologies with behavioral interventions for cigarette smoking and other health-related behavior (e.g., physical activity, medication adherence). Jesse also conducts translational research on choice and decision making in the human laboratory, with a special emphasis on quantitative models of operant behavior. He has published over eighty articles in a diverse range of peer-reviewed journals, and he has received grant support from the National Institutes of Health and from the National Science Foundation. He is co-editor of the book Behavioral Health Care and Technology: Using Science-Based Innovations to Transform Practice. Jesse is a former Associate Editor for The Behavior Analyst and Behavioural Processes, and Special Topics Associate Editor (substance abuse) for the Journal of Applied Behavior Analysis. In 2014, Dr. Dallery was named a Teacher of the Year in the College of Liberal Arts and Sciences.|
Contingency management is one of the most efficacious interventions to promote drug abstinence. Traditionally, contingency management has been delivered in person so that clinicians can confirm drug abstinence and provide access to additional therapeutic services. Now, new technologies not only permit remote confirmation of abstinence, but also remote delivery of incentives. I will discuss several technology-based tools to assess substance use, and new ways to deliver contingency management to promote tobacco and alcohol abstinence. These new tools have the potential to dramatically increase access while maintaining high levels of treatment fidelity. They also allow new ways of arranging contingencies that harness natural, online communities and consequences. Overall, there are unprecedented opportunities to link technology with contingency management to promote drug abstinence.
|Target Audience: |
Board certified behavior analysts; licensed psychologists; graduate students.
|Learning Objectives: At the conclusion of the presentation, participants will be able to: (1) summarize the efficacy literature related to CM interventions for the treatment of substance use disorders; (2) describe the populations and settings appropriate for CM interventions; (3) list potential barriers to dissemination; (4) describe real-world implementation efforts; (5) describe how sensors can be used to obtain objective evidence of at least two different drugs of abuse; (6) describe how information technology can be used to deliver immediate incentives for abstinence; (7) describe how social networks have been used to promote smoking cessation using information technology.|